Mike Pellini
General Partner at Section 32
About
Former CEO of Foundation Medicine through its 2018 acquisition by Roche, and previously President and COO of Clarient (acquired by GE Healthcare). Focused on personalized medicine and oncology, he joined S32 in 2017 and serves on several biotech boards.
Colleagues at Section 32
Alice Cheung
Partner, Talent at Section 32
Allison Pavlick
Investor Relations Principal at Section 32
Andrew Conrad
General Partner at Section 32
Andrew Conrad, PhD
General Partner at Section 32
Andy Harrison
General Partner, CEO at Section 32
Ayesha Arora
Venture Partner at Section 32
Bayan Alizadeh
Partner at Section 32
Bill Maris
General Partner, Founder at Section 32